Danny Hsu Shares The ”I-WISh” Study by Nichola Cooper on ITP
Danny Hsu, President of THANZ, reposted from ITP Australia and New Zealand on LinkedIn:
”Burden of disease in ITP patients is more significant than we think!
Thanks to the I-WISh study by Nichola Cooper, an excellent insight into what ITP patients go through.”
Quoting ITP Australia and New Zealand‘s post:
”Fatigue in ITP: A symptom that demands attention.
The original I‑WISh study highlighted a critical gap: while patients consistently report fatigue as one of the most disruptive aspects of Immune Thrombocytopenia (ITP), it is often under‑recognised in clinical practice.
“Fatigue has impacted my work, relationships, and daily routine.”
Now, I‑WISh 2.0 results are being finalised — with Australia included — offering fresh insights into patient and physician perspectives worldwide.
For healthcare professionals, this is a call to action: fatigue is not secondary.
It is central to the patient experience and must be addressed with empathy and integrated care strategies.
Explore the findings.”
Stay updated on all scientific advances with Hemostasis Today.
-
Feb 7, 2026, 17:00Heghine Khachatryan: Despite Progress, Many People with Hemophilia Remain Undiagnosed Worldwide
-
Feb 7, 2026, 16:53Priyansh Shah and Romit Bhattacharya Address Patients’ Concerns on GLP-1
-
Feb 7, 2026, 16:43Wolfgang Miesbach: Comparing Clinician-Assessed and Patient-Reported Bleeding Scores and Quality of Life
-
Feb 7, 2026, 16:39Olivier Christoph: Where Does Factor VIII Really Come From?
-
Feb 7, 2026, 16:35Tareq Abadl: Low Haptoglobin – Practical Lab Interpretation
-
Feb 7, 2026, 15:58New Study Reveals Higher-Than-Expected Prevalence of Factor VII Deficiency – RPTH Journal
-
Feb 7, 2026, 15:46Tagreed Alkaltham: Blood Crisis Unveiled – Global Shortages, Causes, and Lifesaving Fixes
-
Feb 7, 2026, 15:29Rowan Paul: MSCs Show Strongest Pain Reduction in Regenerative Medicine Approaches
-
Feb 7, 2026, 15:24Abeer Alanazi: Asundexian Reduces Stroke and Mortality Without Increased Bleeding